TrialAutopsyBuilt by Jawad Momani (Pwnedl0l)

Autopsy report · NCT03004443

Inflammation-Induced CNS Glutamate Changes in Depression

Cause of deathStaffing, sites or logistics Automatic label, confidence 0.9, unverified. How labels are made.
“The study was suspended in March 2020 due to the COVID-19 pandemic and ultimately was terminated as it is not safe to test a potent anti-inflammatory drug with ongoing surges of COVID-19.”

The sponsor’s own words in the registry.

Life of this trial

201620172018201920202021202220232024Registered2016-12-08Started2017-05-15Stopped2019-11-27Results posted2023-06-07

Vital statistics

Status
Terminated
Phase
Phase 4
Sponsor
Emory University
Sponsor type
University, hospital or other
Conditions
Depression
Interventions
Infliximab; Placebo
Participants
22
Sites
1
Countries
United States

Trials that died the same way

Look deeper

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.